Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis.

Literature DB >> 18004636

Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis.

Yuko Shimizu, Kazumasa Yokoyama, Tatsuro Misu, Toshiyuki Takahashi, Kazuo Fujihara, Seiji Kikuchi, Yasuto Itoyama, Makoto Iwata.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2007 PMID： 18004636 DOI： 10.1007/s00415-007-0730-5

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

15 in total

1. The clinical course of neuromyelitis optica (Devic's syndrome).

Authors: D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal: Neurology Date: 1999-09-22 Impact factor: 9.910

2. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

Authors: I Nakashima; K Fujihara; I Miyazawa; T Misu; K Narikawa; M Nakamura; S Watanabe; T Takahashi; S Nishiyama; Y Shiga; S Sato; B G Weinshenker; Y Itoyama
Journal: J Neurol Neurosurg Psychiatry Date: 2006-02-27 Impact factor: 10.154

3. An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion.

Authors: M Nakamura; M Endo; K Murakami; H Konno; K Fujihara; Y Itoyama
Journal: Mult Scler Date: 2005-12 Impact factor: 6.312

4. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.

Authors: J I O'Riordan; H L Gallagher; A J Thompson; R S Howard; D P Kingsley; E J Thompson; W I McDonald; D H Miller
Journal: J Neurol Neurosurg Psychiatry Date: 1996-04 Impact factor: 10.154

5. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

Authors: Toshiyuki Takahashi; Kazuo Fujihara; Ichiro Nakashima; Tatsuro Misu; Isabelle Miyazawa; Masashi Nakamura; Shohei Watanabe; Naoto Ishii; Yasuto Itoyama
Journal: Tohoku J Exp Med Date: 2006-12 Impact factor: 1.848

6. Revised diagnostic criteria for neuromyelitis optica.

Authors: D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal: Neurology Date: 2006-05-23 Impact factor: 9.910

7. Brain abnormalities in neuromyelitis optica.

Authors: Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal: Arch Neurol Date: 2006-03

8. Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors: R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal: Ann Neurol Date: 1993-08 Impact factor: 10.422

9. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Authors: Toshiyuki Takahashi; Kazuo Fujihara; Ichiro Nakashima; Tatsuro Misu; Isabelle Miyazawa; Masashi Nakamura; Shohei Watanabe; Yusei Shiga; Chihiro Kanaoka; Juichi Fujimori; Shigeru Sato; Yasuto Itoyama
Journal: Brain Date: 2007-04-19 Impact factor: 13.501

10. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors: Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal: J Exp Med Date: 2005-08-08 Impact factor: 14.307

30 in total

Review 1. A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors: Christopher Eckstein; Shiv Saidha; Michael Levy
Journal: J Neurol Date: 2011-09-20 Impact factor: 4.849

2. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.

Authors: Robert C Axtell; Brigit A de Jong; Katia Boniface; Laura F van der Voort; Roopa Bhat; Patrizia De Sarno; Rodrigo Naves; May Han; Franklin Zhong; Jim G Castellanos; Robert Mair; Athena Christakos; Ilan Kolkowitz; Liat Katz; Joep Killestein; Chris H Polman; René de Waal Malefyt; Lawrence Steinman; Chander Raman
Journal: Nat Med Date: 2010-03-28 Impact factor: 53.440

3. Treatment of neuromyelitis optica: current debate.

Authors: Tomoko Okamoto; Masafumi Ogawa; Youwei Lin; Miho Murata; Sachiko Miyake; Takashi Yamamura
Journal: Ther Adv Neurol Disord Date: 2008-07 Impact factor: 6.570

4. [Therapeutic options for autoimmune encephalomyelitis].

Authors: N Borisow; H Prüss; F Paul
Journal: Nervenarzt Date: 2013-04 Impact factor: 1.214

5. Practice current: How do you treat neuromyelitis optica?

Authors: Aravind Ganesh
Journal: Neurol Clin Pract Date: 2017-04

6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors: Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal: J Neuroinflammation Date: 2016-09-27 Impact factor: 8.322